Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Interleukin (IL) 23 is a heterodimeric cytokine composed of a p19 subunit and the p40 subunit of IL-12. IL-23 affects memory T cell and inflammatory macrophage function through engagement of a novel receptor (IL-23R) on these cells. Recent analysis of the contribution of IL-12 and IL-23 to central nervous system autoimmune inflammation demonstrated that IL-23 rather than IL-12 was the essential cytokine. Using gene-targeted mice lacking only IL-12 (p35−/−) or IL-23 (p19−/−), we show that the specific absence of IL-23 is protective, whereas loss of IL-12 exacerbates collagen-induced arthritis. IL-23 gene-targeted mice did not develop clinical signs of disease and were completely resistant to the development of joint and bone pathology. Resistance correlated with an absence of IL-17–producing CD4+ T cells despite normal induction of collagen-specific, interferon-γ–producing T helper 1 cells. In contrast, IL-12–deficient p35−/− mice developed more IL-17–producing CD4+ T cells, as well as elevated mRNA expression of proinflammatory tumor necrosis factor, IL-1β, IL-6, and IL-17 in affected tissues of diseased mice. The data presented here indicate that IL-23 is an essential promoter of end-stage joint autoimmune inflammation, whereas IL-12 paradoxically mediates protection from autoimmune inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




![Figure 5. A model proposing the respective roles of IL-12/IFN-γ and IL-23 in T cell-priming events versus end-stage autoimmune inflammation. The precise mechanism through which IL-12/IFN-γ may down-regulate the magnitude of the inflammatory response (i.e., reducing IL-17 production) remains to be defined. It is recognized that IFN-γ may have dual roles during late-stage inflammation (i.e., antiinflammatory actions through termination of activated T cell responses [references 9, 29] while also stimulating macrophage function [reference 5]). a, The IL-23R is present on CD4+ CD45RBlo “memory” T cells (30), but this cell phenotype may also include activated CD4+ T cells that are not strictly memory T cells.](https://figures.cochat.ai/paper-figures/7aaa8df7955d4b7f85c0b7ac367626a2/divergent-pro-and-antiinflammatory-roles-for-il-23-and-il-12-in-joint-autoimmune-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Th17 cells, originally described in mice as being pathogenic in murine models of autoimmune disease [181, 182], have more recently been shown to protect against certain pathogens, including fungal infections [183].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [182]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Self-citationOppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,822
Self-citationAggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Parham, C., Chirica, M., Timans, J., Vaisberg, E., Travis, M., Cheung, J., Pflanz, S., Zhang, R., Singh, K. P., Vega, F., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5699 · Cited by 1,296
Self-citationRapid and coordinated switch in chemokine receptor expression during dendritic cell maturation
Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Qin, S., & Lanzavecchia, A. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199809)28:09<2760::aid-immu2760>3.0.co;2-n · Cited by 1,183
Immunisation against heterologous type II collagen induces arthritis in mice
Courtenay, J. S., Dallman, M. J., Dayan, A. D., Martin, A., & Mosedale, B. (1980) · Nature · doi:10.1038/283666a0 · Cited by 1,025
Luster, A. D., Unkeless, J. C., & Ravetch, J. V. (1985) · Nature · doi:10.1038/315672a0 · Cited by 944
Willenborg, D. O., Fordham, S., Bernard, C. C., Cowden, W. B., & Ramshaw, I. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3223 · Cited by 635
Ziolkowska, M., Koc, A., Luszczykiewicz, G., Ksiezopolska-Pietrzak, K., Klimczak, E., Chwalinska-Sadowska, H., & Maslinski, W. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2832 · Cited by 580 · cited 1×
“IL-17 is a potent proinflammatory cytokine produced by PBMCs/T cells and by cells isolated from synovial fluid of rheumatoid arthritis patients (27).”
BackgroundAccelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice
Vermeire, K., Heremans, H., Vandeputte, M., Huang, S., Billiau, A., & Matthys, P. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5507 · Cited by 458
Cited by
Items 601–700 of 1,001
Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo
Bosisio, D., Vulcano, M., Prete, A. D., Sironi, M., Salvi, V., Salogni, L., Riboldi, E., Leoni, F., Dinarello, C. A., Girolomoni, G., et al. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0708401 · Cited by 74
Metabolic characterisation of THP-1 macrophage polarisation using LC–MS-based metabolite profiling
Abuawad, A., Mbadugha, C., Ghaemmaghami, A. M., & Kim, D. (2020) · Metabolomics · doi:10.1007/s11306-020-01656-4 · Cited by 81
Pathogenesis of Non-Infectious Uveitis Elucidated by Recent Genetic Findings
Takeuchi, M., Mizuki, N., & Ohno, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640473 · Cited by 78
Song, X., Shen, J., Wen, H., Zhong, Z., Luo, Q., Chu, D., Qi, Y., Xu, Y., & Wei, W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023453 · Cited by 70
Zizzo, G., Santis, M. D., Bosello, S. L., Fedele, A. L., Peluso, G., Gremese, E., Tolusso, B., & Ferraccioli, G. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.10.002 · Cited by 75
Relative roles of Th1 and Th17 effector cells in allograft rejection
Atalar, K., Afzali, B., Lord, G. M., & Lombardi, G. (2009) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32831b70c2 · Cited by 75
Cell signalling in macrophages, the principal innate immune effector cells of rheumatoid arthritis
Drexler, S. K., Kong, P. L., Wales, J., & Foxwell, B. M. J. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2481 · Cited by 78
IL-17-producing T cells can augment autoantibody-induced arthritis
Jacobs, J. P., Wu, H.-J., Benoist, C., & Mathis, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912152106 · Cited by 71
Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders
Balato, A., Scala, E., Balato, N., Caiazzo, G., Caprio, R. D., Monfrecola, G., Raimondo, A., Lembo, S., & Ayala, F. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1363884 · Cited by 74
Maarouf, M., Clark, A. K., Lee, D. E., & Shi, V. Y. (2017) · Journal of Dermatological Treatment · doi:10.1080/09546634.2017.1395806 · Cited by 73
Xia, T., Zheng, X., Qian, B., He, F., Wang, J., Zhang, L.-L., Pang, Y., Zhang, J., Wei, X., Xia, Z., et al. (2015) · Disease Markers · doi:10.1155/2015/795043 · Cited by 69
Th17 Differentiation and Their Pro-inflammation Function
Song, X., Gao, H., & Qian, Y. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-9487-9_5 · Cited by 74
Immunomodulator therapy: Monoclonal antibodies, fusion proteins, cytokines, and immunoglobulins
Lee, S. H., Chinen, J., & Kavanaugh, A. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.08.018 · Cited by 80
Vandenbroeck, K. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0103 · Cited by 76
Hildner, K. M., Schirmacher, P., Atreya, I., Dittmayer, M., Bartsch, B., Galle, P. R., Wirtz, S., & Neurath, M. F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3427 · Cited by 68
Th17 cells can provide B cell help in autoantibody induced arthritis
Hickman‐Brecks, C. L., Racz, J. L., Meyer, D. M., LaBranche, T. P., & Allen, P. M. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2010.10.007 · Cited by 73
Ng, S. C., Kamm, M. A., Stagg, A. J., & Knight, S. C. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21247 · Cited by 81
Role of Th17 Cytokines in Airway Remodeling in Asthma and Therapy Perspectives
Margelidon-Cozzolino, V., Tsicopoulos, A., Chenivesse, C., & de Nadaï, P. (2022) · Frontiers in Allergy · doi:10.3389/falgy.2022.806391 · Cited by 77
Wang, S., Essien‐Baidoo, S., Liu, Y., Zhu, C., Tian, J., Ma, J., Tong, J., Chen, J., Tang, X., Xu, H., et al. (2012) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2012.04670.x · Cited by 68
Duan, L., Wang, C., Chen, J., Gong, Q., Zhu, P., Zheng, F., Tan, Z., Gong, F., & Fang, M. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.141 · Cited by 74
A complex issue on CD 4+ T‐cell subsets
Jiang, S., & Dong, C. (2013) · Immunological Reviews · doi:10.1111/imr.12041 · Cited by 103
Piper, C., Pesenacker, A. M., Bending, D., Thirugnanabalan, B., Varsani, H., Wedderburn, L. R., & Nistala, K. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38647 · Cited by 67
T-helper cells as new players in ANCA-associated vasculitides
Abdulahad, W. H., Lamprecht, P., & Kallenberg, C. G. M. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3362 · Cited by 80
Ye, L., Wen, Z., Li, Y., Chen, B., Yu, T. Y., Liu, L., Zhang, J., Ma, Y., Xiao, S., Ding, L., et al. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4544 · Cited by 74
Replication of an Association Between IL23R Gene Polymorphism With Inflammatory Bowel Disease
Oliver, J., Rueda‐Medina, B., López‐Nevot, M. Á., Gómez–García, M., & Martin, J. J. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.05.002 · Cited by 75
Evidence for anti‐inflammatory effects of C5a on the innate IL‐17A/IL‐23 axis
Bosmann, M., Sarma, J. V., Atefi, G., Zetoune, F. S., & Ward, P. A. (2012) · The FASEB Journal · doi:10.1096/fj.11-199216 · Cited by 67
Nitric Oxide–Induced Regulatory T Cells Inhibit Th17 but Not Th1 Cell Differentiation and Function
Niedbała, W., Besnard, A., Jiang, H., Alves-Filho, J. C., Fukada, S. Y., Nascimento, D., Mitani, A., Pushparaj, P. N., Al-Qahtani, M. H., & Liew, F. Y. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202580 · Cited by 76
Yao, Y., Yang, W., Yang, Y., Ma, H.-D., Lu, F.-T., Li, L., Tao, Y.-Y., Tsuneyama, K., Zhang, W., Friedman, S. L., et al. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.02.009 · Cited by 68
At the crossroads of T helper lineage commitment—Epigenetics points the way
Janson, P., Winerdal, M. E., & Winqvist, O. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.12.003 · Cited by 71
Blowing on Embers: Commensal Microbiota and Our Immune System
Spasova, D. S., & Surh, C. D. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00318 · Cited by 78
Woś, I., & Tabarkiewicz, J. (2021) · Immunologic Research · doi:10.1007/s12026-021-09173-9 · Cited by 70
Structural basis of IL-23 antagonism by an Alphabody protein scaffold
Desmet, J., Verstraete, K., Bloch, Y., Lorent, E., Wen, Y., Devreese, B. V., Vandenbroucke, K., Loverix, S., Hettmann, T., Deroo, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms6237 · Cited by 73
Interleukin‐4 can be a key positive regulator of inflammatory arthritis
Ohmura, K., Nguyen, L. T., Locksley, R. M., Mathis, D. J., & Benoist, C. O. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21104 · Cited by 66
The clinical role of IL‐23p19 in patients with rheumatoid arthritis
Kim, H. ‐., Kim, H. ‐., Park, M.-W., Cho, M. ‐., Lee, S. ‐., & Kim, H. ‐. (2007) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740701286813 · Cited by 73
Imamura, M., Okunishi, K., Ohtsu, H., Nakagome, K., Harada, H., Tanaka, R., Yamamoto, K., & Dohi, M. (2008) · Thorax · doi:10.1136/thx.2007.094540 · Cited by 69
Seymour, B. J., Trent, B. J., Allen, B. E., Berlinberg, A. J., Tangchittsumran, J., Jubair, W. K., Chriswell, M. E., Liu, S., Ornelas, A., Stahly, A., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci167671 · Cited by 73
New Interleukin-23 Pathway Inhibitors in Dermatology: Ustekinumab, Briakinumab, and Secukinumab
Kurzeja, M., Rudnicka, L., & Olszewska, M. (2011) · American Journal of Clinical Dermatology · doi:10.2165/11538950-000000000-00000 · Cited by 71
The role of IL-23 in the immunopathogenesis of psoriasis
Meglio, P. D., & Nestle, F. O. (2010) · F1000 Biology Reports · doi:10.3410/b2-40 · Cited by 74
The interleukin-23/interleukin-17 axis in spondyloarthritis
Layh‐Schmitt, G., & Colbert, R. A. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328303204b · Cited by 76
Interleukin-17 stimulates inducible nitric oxide synthase-dependent toxicity in mouse beta cells
Miljković, D. M., Cvetković, I., Momčilović, M. B., Maksimović‐Ivanić, D., Stošić‐Grujičić, S., & Trajković, V. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5259-0 · Cited by 70
Egan, P. J., van Nieuwenhuijze, A. E. M., Campbell, I. K., & Wicks, I. P. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24075 · Cited by 73
2´-Deoxy Purine, 2´-O-Methyl Pyrimidine (dRmY) Aptamers as Candidate Therapeutics
Burmeister, P. E., Wang, C., Killough, J. R., Lewis, S. D., Horwitz, L. R., Ferguson, A., Thompson, K. M., Pendergrast, P. S., McCauley, T. G., Kurz, M., et al. (2006) · Oligonucleotides · doi:10.1089/oli.2006.16.337 · Cited by 64
Xia, L., Tian, D., Huang, W., Zhu, H., Wang, J., Zhang, Y., Hu, H., Nie, Y., Fan, D., & Wu, K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101652 · Cited by 66
Bianchi, E., & Rogge, L. (2019) · Genes and Immunity · doi:10.1038/s41435-019-0067-y · Cited by 69
Vitamin D insufficiency in a large MCTD population
Hajas, Á., Sándor, J., Csáthy, L., Csípő, I., Baráth, S., Paragh, G., Seres, I., Szegedi, G., Shoenfeld, Y., & Bodolay, E. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.11.006 · Cited by 66
Biologics : Target - specific treatment of systemic and cutaneous autoimmune diseases
Raychaudhuri, S. P., & Raychaudhuri, S. (2009) · Indian Journal of Dermatology · doi:10.4103/0019-5154.53175 · Cited by 73
IL-23 and Th17 Disease in Inflammatory Arthritis
Yago, T., Nanke, Y., Kawamoto, M., Kobashigawa, T., Yamanaka, H., & Kotake, S. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6090081 · Cited by 69
Floss, D. M., Mrotzek, S. M., Klöcker, T., Schröder, J., Grötzinger, J., Rose‐John, S., & Scheller, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.432153 · Cited by 66
Interleukin-17: friend or foe in atherosclerosis?
Taleb, S., Tedgui, A., & Mallat, Z. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833dc7f9 · Cited by 63
El-Hed, A., & Unutmaz, D. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833647a8 · Cited by 78
Current perspectives on the role of IL-17 in autoimmune disease
Yamada, H. (2010) · Journal of Inflammation Research · doi:10.2147/jir.s6375 · Cited by 72
Aravena, O., Pesce, B., Soto, L., Orrego, N., Sabugo, F., Wurmann, P., Molina, M. C., Jorge Alfaro, L., Cuchacovich, M., Aguillón, J. C., et al. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.07.006 · Cited by 71
Steward-Tharp, S. M., Song, Y.-J., Siegel, R. M., & O’Shea, J. J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05124.x · Cited by 67
The severity of experimental arthritis is independent of IL-36 receptor signaling
Lamacchia, C., Palmer, G., Rodriguez, E., Martin, P., Vigne, S., Seemayer, C. A., Talabot‐Ayer, D., Towne, J. E., & Gabay, C. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4192 · Cited by 63
Kageyama, Y., Ichikawa, T., Nagafusa, T., Torikai, E., Shimazu, M., & Nagano, A. (2007) · Rheumatology International · doi:10.1007/s00296-007-0388-4 · Cited by 66
CCR6 as a possible therapeutic target in psoriasis
Hedrick, M. N., Lonsdorf, A. S., Hwang, S. T., & Farber, J. M. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.504716 · Cited by 68
The transient nature of the Th17 phenotype
Annunziato, F., & Romagnani, S. (2010) · European Journal of Immunology · doi:10.1002/eji.201041145 · Cited by 70
Tim-3 promotes intestinal homeostasis in DSS colitis by inhibiting M1 polarization of macrophages
Jiang, X., Yu, J., Shi, Q., Xiao, Y., Wang, W., Chen, G., Zhao, Z. J., Wang, R., He, X., Hou, C., et al. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.07.008 · Cited by 64
Distinct roles of helper T-cell subsets in a systemic autoimmune disease
Hoyer, K. K., Kuswanto, W. F., Gallo, E., & Abbas, A. K. (2008) · Blood · doi:10.1182/blood-2008-04-153346 · Cited by 71
Early administration of IL-12 suppresses EAE through induction of interferon-γ
Gran, B., Chu, N., Zhang, G., Yu, S., Li, Y., Chen, X., Kamoun, M., & Rostami, A. M. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.07.019 · Cited by 62
Targeting IL-17 in autoimmunity and inflammation
Kim, B. S., Park, Y.-J., & Chung, Y. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0823-8 · Cited by 66
Huang, Z., Xie, H., Wang, R., & Sun, Z. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.6.737 · Cited by 61
“A correlation between IL-23-dependent TH17 cells and the development of autoimmune diseases is thus established [23,25,29].”
BackgroundNovel genetic markers in inflammatory bowel disease
Rodríguez-Bores, L., Fonseca, G.-C., Villeda, M.-A., & Yamamoto-Furusho, J.-K. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i42.5560 · Cited by 70
Cytokine profiles and T cell function in acute coronary syndromes
Steppich, B., Moog, P., Matissek, C., Wisniowski, N., Kühle, J., Joghetaei, N., Neumann, F., Schömig, A., & Ott, I. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.02.034 · Cited by 67
Villarino, A. V., & Hunter, C. A. (2004) · Arthritis Research · doi:10.1186/ar1227 · Cited by 71
Siegemund, S., Schutze, N., Schulz, S., Wolk, K., Nasilowska, K., Straubinger, R. K., Sabat, R., & Alber, G. (2009) · International Immunology · doi:10.1093/intimm/dxp025 · Cited by 70
IL-23 Enhances Host Defense against Vaccinia Virus Infection Via a Mechanism Partly Involving IL-17
Kohyama, S., Ohno, S., Isoda, A., Moriya, O., Belladonna, M. L., Hayashi, H., Iwakura, Y., Yoshimoto, T., Akatsuka, T., & Matsui, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3917 · Cited by 62
Critical role of the interleukin‐23//T‐helper 17 cell axis in the pathogenesis of psoriasis
Nakajima, K. (2012) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2011.01458.x · Cited by 67
Mauermann, N., Burian, J., von Garnier, C., Dirnhofer, S., Germano, D., Schuett, C., Tamm, M., Bingisser, R. M., Eriksson, U., & Hunziker, L. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1648oc · Cited by 60
The role of IL-17 in systemic lupus erythematosus and its potential as a therapeutic target
Koga, T., Ichinose, K., Kawakami, A., & Tsokos, G. C. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1593141 · Cited by 66
Tu, L., Li, S., Fu, Y., Yao, R., Zhang, Z., Yang, S., Zeng, X., & Kuang, N. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.04.001 · Cited by 59
The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases
Gabay, C., & McInnes, I. B. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2680 · Cited by 71
Investigating the role of the interleukin-23/-17A axis in rheumatoid arthritis
Hillyer, P., LARCHÉ, M. J., Bowman, E. P., McClanahan, T. K., Malefyt, R. D. W., Schewitz‐Bowers, L. P., Giddins, G. E. B., Feldmann, M., KASTELEIN, R. A., & Brennan, F. M. (2009) · Rheumatology · doi:10.1093/rheumatology/kep293 · Cited by 61
Self-citationChang, L.-H., Huang, H., Wu, P., Jou, I., Pan, M., Chang, W., Wang, D. D. H., & Wang, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045378 · Cited by 65
Zhao, Z., Hou, X., Yin, X., Li, Y., Duan, R., Boyce, B. F., & Yao, Z. (2015) · PLOS ONE · doi:10.1371/journal.pone.0135728 · Cited by 57
Dankers, W., Davelaar, N., van Hamburg, J. P., van de Peppel, J., Colin, E. M., & Lubberts, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01504 · Cited by 61
Koga, T., Ichinose, K., Kawakami, A., & Tsokos, G. C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.624971 · Cited by 68
Rationale and safety of anti-interleukin-23 and anti-interleukin-17A therapy
Bowman, E. P., Chackerian, A. A., & Cua, D. J. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000224818.42729.67 · Cited by 58
Self-citationLee, J. S., Kim, S. G., Kim, H. K., Lee, T., Jeong, Y., Lee, C., Yoon, M., Na, Y. J., Suh, D., Park, N. C., et al. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20852 · Cited by 58
Celastrol suppresses humoral immune responses and autoimmunity by targeting the COMMD3/8 complex
Shirai, T., Nakai, A., Ando, E., Fujimoto, J., Leach, S., Arimori, T., Higo, D., van Eerden, F. J., Tulyeu, J., Liu, Y., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.adc9324 · Cited by 62
SOCS1 is a critical checkpoint in immune homeostasis, inflammation and tumor immunity
Bidgood, G. M., Keating, N., Doggett, K., & Nicholson, S. E. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1419951 · Cited by 66
Coffre, M., Roumier, M., Rybczynska, M., Sechet, E., Law, H. K. W., Gossec, L., Dougados, M., Bianchi, E., & Rogge, L. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37936 · Cited by 56
Park, S. Y., Gupta, D., Kim, C. H., & Dziarski, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024961 · Cited by 61
Th17 Cells in Type 1 Diabetes: Role in the Pathogenesis and Regulation by Gut Microbiome
Li, Y., Liu, Y., & Chu, C. (2015) · Mediators of Inflammation · doi:10.1155/2015/638470 · Cited by 63
Therapeutic implications of autoantibodies in rheumatoid arthritis
Aletaha, D., & Blüml, S. (2016) · RMD Open · doi:10.1136/rmdopen-2014-000009 · Cited by 62
Shan, B. E., Hao, J. S., Li, Q. X., & Tagawa, M. (2006) · PubMed · Cited by 57
Nieuwenhove, E. V., Lagou, V., Eyck, L. V., Dooley, J., Bodenhofer, U., Roca, C. P., Vandebergh, M., Goris, A., Humblet‐Baron, S., Wouters, C. H., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214354 · Cited by 62
Lamacchia, C., Palmer, G., Seemayer, C. A., Talabot‐Ayer, D., & Gabay, C. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27235 · Cited by 55
Dendritic cells and interferon-mediated autoimmunity
Gottenberg, J., & Chiocchia, G. (2007) · Biochimie · doi:10.1016/j.biochi.2007.04.013 · Cited by 58
Liu, W. Y., Sun, Y., Cheng, Z., Guo, Y. S., Liu, P., & Wen, Y. (2018) · Pharmaceutical Biology · doi:10.1080/13880209.2018.1448874 · Cited by 58
Th17 and Th1 Lymphocytes in Oligoarticular Juvenile Idiopathic Arthritis
Maggi, L., Mazzoni, A., Cimaz, R., Liotta, F., Annunziato, F., & Cosmi, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00450 · Cited by 62
Miossec, P. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00644-5 · Cited by 67
New complexities in helper T cell fate determination and the implications for autoimmune diseases
Takatori, H., Kanno, Y., Chen, Z., & O’Shea, J. J. (2008) · Modern Rheumatology · doi:10.1007/s10165-008-0099-z · Cited by 55
Andreadou, M., Ingelfinger, F., Feo, D. D., Cramer, T. L. M., Tuzlak, S., Friebel, E., Schreiner, B., Eede, P., Schneeberger, S., Geesdorf, M., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01435-z · Cited by 65
Development of a Bioengineered Skin-Humanized Mouse Model for Psoriasis
Guerrero‐Aspizua, S., García, M., Murillas, R., Retamosa, L., Illera, N., Duarte, B., Holguín, A., Puig, S., Hernández, M. I., Meana, Á., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100078 · Cited by 56
IL-23 Receptor Regulation by Let-7f in Human CD4+ Memory T Cells
Li, Z., Wu, F., Brant, S. R., & Kwon, J. H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000917 · Cited by 60
Shi, M., Wang, A., Prescott, D., Waterhouse, C. C. M., Zhang, S., McDougall, J. J., Sharkey, K. A., & McKay, D. M. (2010) · Arthritis & Rheumatism · doi:10.1002/art.30098 · Cited by 60
IRAK4 Kinase Activity Is Required for Th17 Differentiation and Th17-Mediated Disease
Staschke, K. A., Dong, S., Saha, J. K., Zhao, J., Brooks, N. A., Hepburn, D. L., Xia, J., Gulen, M. F., Kang, Z., Altuntas, C. Z., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802361 · Cited by 59
IL-23 inhibition for chronic inflammatory disease
Jairath, V., Felquer, M. L. A., & Cho, R. J. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01750-1 · Cited by 64
T‐cell receptor signaling and the pathogenesis of autoimmune arthritis: insights from mouse and man
Sakaguchi, S., Benham, H., Cope, A. P., & Thomas, R. (2012) · Immunology and Cell Biology · doi:10.1038/icb.2012.4 · Cited by 58
Metadata
- Authors
- Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, R. A., Sedgwick, J. D., & Cua, D. J.
- Affiliations
- 1Discovery Research, DNAX Research Inc., Palo Alto, CA 94304
- 2Experimental Pathology and Pharmacology, DNAX Research Inc., Palo Alto, CA 94304
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-12-08
- Volume
- 198
- Issue
- 12
- Pages
- 1951-1957
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2194162
- OpenAlex
- W2116828514
- Cited by
- 1,669
- References
- 32
- Citations by year
- 2026: 18 · 2025: 14 · 2024: 27 · 2023: 31 · 2022: 34 · 2021: 42 · 2020: 46 · 2019: 53 · 2018: 53 · 2017: 56 · 2016: 55 · 2015: 76 · 2014: 75 · 2013: 98 · 2012: 105
- FWCI
- 15.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IL-23, IL-12, collagen-induced arthritis, IL-17-producing T cells, CD4+ T cells, Th1 cells, IL23R, bone pathology, inflammatory cytokines, TNF-α, IL-1β, interleukin-6, IL-17
- MeSH terms
- Animals, Arthritis, Experimental, Female, Interferon-gamma, Interleukins, Male, Mice, Inbred C57BL, T-Lymphocytes, Tumor Necrosis Factor-alpha, Interleukin-12, Interleukin-17, Collagen Type II, Mice, Interleukin-23, Interleukin-23 Subunit p19
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.